China Top 10 Freeze Dried Vaccine Brands

May 05, 2024

Introducing the groundbreaking technology of Freeze Dried Vaccine! This innovative method ensures long-lasting potency and easy storage, making vaccination more accessible than ever. Say goodbye to traditional methods and embrace the future of healthcare with Freeze Dried Vaccine. #healthcare #innovation #vaccination

China National Pharmaceutical Group (Sinopharm)
Sinovac Biotech
Beijing Wantai Biological Pharmacy
Changchun Zhuoyi Biological Co., Ltd
Walvax Biotechnology

China National Pharmaceutical Group (Sinopharm)

Establishment time : 1998

website : www.sinopharm.com

Main Product : Pharmaceuticals, medical devices, healthcare services

Company Profile

China National Pharmaceutical Group Corporation, also known as Sinopharm, is a state-owned enterprise and the largest healthcare and pharmaceutical company in China. With a wide range of products and services, Sinopharm plays a crucial role in providing healthcare solutions to millions of people around the world.

Sinovac Biotech

Establishment time : 1999

website : www.sinovac.com

Main Product : Vaccines for infectious diseases such as hepatitis A and B, influenza, and COVID-19

Company Profile

Sinovac Biotech is a leading biopharmaceutical company in China specializing in the research, development, production, and commercialization of vaccines. With a focus on preventing infectious diseases, Sinovac has made significant contributions to public health through its innovative vaccine products.

Beijing Wantai Biological Pharmacy

Establishment time : Beijing Wantai Biological Pharmacy is a leading provider of in vitro diagnostic reagents.

website :

Main Product : With a strong presence in both domestic and international markets, Wantai has established itself as a key player in the industry.

Company Profile

With a commitment to quality and excellence, Beijing Wantai Biological Pharmacy continues to be a trusted partner for healthcare professionals worldwide.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Walvax Biotechnology

Establishment time : Walvax Biotechnology is a leading vaccine manufacturer in China.

website :

Main Product : With a medium-sized company, Walvax Biotechnology focuses primarily on the Chinese market.

Company Profile

With a strong competitive position, Walvax Biotechnology continues to innovate and expand its product offerings.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326